General Information of Drug (ID: DR1797)
Drug Name
EGYT-3886
Synonyms
Deramciclane; Deramciclane [INN]; Deramclclane; EGIS-3886; EGYT-3886; EGYT3886; Egyt 3886; O5KFK61E74; QOBGWWQAMAPULA-RLLQIKCJSA-N; SCHEMBL548911; deramciclane, (1R,2S,4R)-isomer; 120444-71-5; BCP21344; CHEMBL2104698; CTK0H6513; DTXSID10152862; Ethanamine, N,N-dimethyl-2-(((1R,2S,4R)-1,7,7-trimethyl-2-phenylbicyclo(2.2.1)hept-2-yl)oxy)-; Ethanamine, N,N-dimethyl-2-((1,7,7-trimethyl-2-phenylbicyclo(2.2.1)hept-2-yl)oxy)-, (1R-exo)-; GTPL5490; N,N-Dimethyl-2-(((1R,2S,4R)-2-phenyl-2-bornyl)oxy)ethylamine; UNII-O5KFK61E74
Indication Anxiety disorder [ICD11: 6B00] Discontinued [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 301.5 Topological Polar Surface Area 12.5
Heavy Atom Count 22 Rotatable Bond Count 5
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 2
Cross-matching ID
PubChem CID
119590
PubChem SID
16241831 ; 29300432 ; 50064251 ; 57339571 ; 74485793 ; 135107097 ; 136292470 ; 137147719 ; 144235383 ; 160697964 ; 163305281 ; 176251686 ; 178102137 ; 179149694 ; 198935447 ; 219813681 ; 223609753 ; 223957136 ; 226857741 ; 252215266
CAS Number
120444-71-5
TTD Drug ID
D0E6UA
Formula
C20H31NO
Canonical SMILES
CC1(C2CCC1(C(C2)(C3=CC=CC=C3)OCCN(C)C)C)C
InChI
1S/C20H31NO/c1-18(2)17-11-12-19(18,3)20(15-17,22-14-13-21(4)5)16-9-7-6-8-10-16/h6-10,17H,11-15H2,1-5H3/t17-,19-,20+/m1/s1
InChIKey
QOBGWWQAMAPULA-RLLQIKCJSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
1-hydroxy-deramciclane DM005591
154731612
Unclear 1 [3]
Carboxy-deramciclane DM005588 N. A. Unclear 1 [3]
Deramciclane N-oxide DM005590
88200129
Unclear 1 [3]
Dihydroxy-deramciclane DM005592 N. A. Unclear 1 [3]
Hydroxy-phenylborneol DM005587 N. A. Unclear 1 [3]
N-desmethyl carboxy-deramciclane DM005589 N. A. Unclear 1 [3]
N-desmethyl deramciclane DM005585
57188424
Unclear 1 [3]
Phenylborneol DM005586
10721413
Unclear 1 [3]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR005955 EGYT-3886 N-desmethyl deramciclane Unclear Unclear [3]
MR005956 EGYT-3886 Phenylborneol Unclear Unclear [3]
MR005957 EGYT-3886 Hydroxy-phenylborneol Unclear Unclear [3]
MR005958 EGYT-3886 Carboxy-deramciclane Unclear Unclear [3]
MR005959 EGYT-3886 N-desmethyl carboxy-deramciclane Unclear Unclear [3]
MR005960 EGYT-3886 Deramciclane N-oxide Unclear Unclear [3]
MR005961 EGYT-3886 1-hydroxy-deramciclane Unclear Unclear [3]
MR005962 EGYT-3886 Dihydroxy-deramciclane Unclear Unclear [3]
⏷ Show the Full List of 8 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 2E1 (CYP2E1) DME0013 Homo sapiens
CP2E1_HUMAN
1.14.14.1
[2]
References
1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001479)
2 Role of CYP2E1 in deramciclane metabolism. Drug Metab Dispos. 2005 Nov;33(11):1717-22.
3 Biotransformation of deramciclane in primary hepatocytes of rat, mouse, rabbit, dog, and human

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.